Clinical Trial Update: Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery [NA]

View source ↗

Summary

A completed clinical trial compared the Hydrus Microstent to the iStent for lowering intraocular pressure in glaucoma patients undergoing cataract surgery; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma
• Pigmentary Glaucoma
• Pseudoexfoliation Glaucoma

Drugs mentioned

• Hydrus Microstent
• iStent

Snippet

Sponsor: Ivantis, Inc. | Conditions: Primary Open Angle Glaucoma, Pseudoexfoliative Glaucoma | NA | Status: COMPLETED | Results posted: 2024-06-21